Concepedia

Mercedes Lioni

ML

Statistics

Publications

8

Citations

1.4K

H-Index

8

Active since

2006

Affiliations

The Wistar Institute(Current)

University of Pennsylvania

GlaxoSmithKline (United States)

Fox Chase Cancer Center

Mercedes Lioni is an author at The Wistar Institute specializing in oncology, medicine, and molecular oncology.

Publications per year

2006–2013

8

Publications

8

Multiple signaling pathways must be targeted to overcome drug resistance in cell lines derived from melanoma metastases

Keiran S.M. Smalley, Nikolas K. Haass, Patricia Brafford et al. · Molecular Cancer Therapeutics · 2006 · 460 citations

, , +17

Increased cyclin D1 expression can mediate BRAF inhibitor resistance in <i>BRAF</i> V600E–mutated melanomas

Keiran S.M. Smalley, Mercedes Lioni, Maurizia Dalla Palma et al. · Molecular Cancer Therapeutics · 2008 · 293 citations · Full text

, , +17

Dysregulation of Claudin-7 Leads to Loss of E-Cadherin Expression and the Increased Invasion of Esophageal Squamous Cell Carcinoma Cells

Mercedes Lioni, Patricia Brafford, Claudia D. Andl et al. · American Journal Of Pathology · 2007 · 135 citations · Full text

, , +11

The Essential Role of Fibroblasts in Esophageal Squamous Cell Carcinoma–Induced Angiogenesis

Kazuhiro Noma, Keiran S.M. Smalley, Mercedes Lioni et al. · Gastroenterology · 2008 · 132 citations · Full text

, , +12

<i>In vitro</i>three-dimensional tumor microenvironment models for anticancer drug discovery

Keiran S.M. Smalley, Mercedes Lioni, Kazuhiro Noma et al. · Expert Opinion on Drug Discovery · 2007 · 130 citations

, , +15

1–5 of 8